Literature DB >> 9035182

C3 nephritic factor and mesangiocapillary glomerulonephritis.

D G Williams1.   

Abstract

The association of a C3 splitting activity, known as C3 nephritic factor (C3NeF), with mesangiocapillary glomerulonephritis (MCGN), especially MCGN type II, has long been known. Several forms of C3NeF are now recognised, the main one being an IgG which acts as an autoantibody binding to factor H, a normally occurring component of the complement system. Complement is in a continuous state of activation with inbuilt checks and controls, and factor H plays a very important part in the controlling mechanisms by preventing the overwhelming activation of complement at the stage of C3 conversion. C3NeF binds to factor H, thus preventing its inhibitory action, and allowing complement activation to proceed with, in vivo, the well-known consequences in MCGN of very low serum levels of C3. The question naturally arose whether C3NeF causes MCGN. Complex relationships between MCGN, C3NeF and partial lipodystrophy, also characterised by C3NeF and hypocomplementaemia, but preceding the development of MCGN, suggest that hypocomplementaemia predisposes to MCGN. Another possibility is that C3NeF acts directly within glomeruli to cause local complement activation and ensuing damage. Neither possibility could be resolved, but some recent observations have restimulated interest in a possible causative role for C3NeF in MCGN. First, factor H deficiency, by mechanisms other than blocking by C3NeF, in animals and man is associated with MCGN. Second, adipocytes, now known themselves to produce complement system proteins, are lysed in vitro by C3NeF, thus suggesting a mechanism for partial lipodystrophy. By analogy, the C3NeF may produce glomerular damage, as glomerular cells produce complement components.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9035182     DOI: 10.1007/s004670050241

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  6 in total

1.  Favorable outcome in a case of Mycoplasma pneumoniae-associated crescentic glomerulonephritis.

Authors:  Anne-Laure Adra; Marie-Gabrielle Vigue; Fabienne Dalla Vale; Lydia Ichay; Pierre Raynaud; Aude Mariani; Denis Morin
Journal:  Pediatr Nephrol       Date:  2010-03-25       Impact factor: 3.714

2.  Circulating complement levels and C3 glomerulopathy.

Authors:  Fernando C Fervenza; Sanjeev Sethi
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-23       Impact factor: 8.237

3.  Complement factor H-related hybrid protein deregulates complement in dense deposit disease.

Authors:  Qian Chen; Michael Wiesener; Hannes U Eberhardt; Andrea Hartmann; Barbara Uzonyi; Michael Kirschfink; Kerstin Amann; Maike Buettner; Tim Goodship; Christian Hugo; Christine Skerka; Peter F Zipfel
Journal:  J Clin Invest       Date:  2013-12-16       Impact factor: 14.808

Review 4.  Membranoproliferative glomerulonephritis.

Authors:  Bassam Alchi; David Jayne
Journal:  Pediatr Nephrol       Date:  2009-11-12       Impact factor: 3.714

5.  Familial partial lipodystrophy and proteinuric renal disease due to a missense c.1045C > T LMNA mutation.

Authors:  Athanasios Fountas; Zoe Giotaki; Evangelia Dounousi; George Liapis; Alexandra Bargiota; Agathocles Tsatsoulis; Stelios Tigas
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-06-02

6.  Novel factor H mutation associated with familial membranoproliferative glomerulonephritis type I.

Authors:  Hadas Alfandary; Miriam Davidovits
Journal:  Pediatr Nephrol       Date:  2015-08-20       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.